The global cell lysis market size is projected to reach USD 4.1 billion by 2026 from USD 2.9 billion in 2021, at a CAGR of 7.2% during the forecast period.
Factors Driving the Market Growth:
Growth of the market is driven mainly by increasing government funding for research, high prevalence of diseases and growing focus on personalized medicine.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260138321
Consumables accounted for the larger share of the cell lysis market in 2020
Based on the product, the cell lysis market is segmented into consumables and instruments. In 2020, the consumables segment accounted for the larger share of the cell lysis market. The large share of this segment can be attributed to repeated purchase and high consumption, the high prevalence of diseases, and increasing funding for cell-based research.
By cell type, the mammalian cells segment accounted for the largest market share in 2020
Based on the cell type, the cell lysis market is segmented into mammalian cell, microbial cell and other cell. The mammalian cell segment accounted for the largest market share in 2020. The increasing investments in research activities to develop new disease treatments and industrial applications are major driving factors for this market.
Research laboratories and institutes are the largest end-users of the cell lysis market
Based on end-users, the cell lysis market is segmented into research laboratories & institutes, biopharmaceutical & biotechnology companies, and other end users. The research laboratories & institutes segment accounted for the largest market share in 2020 due to the increasing number of rising government funding for cell-based research.
Request for Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=260138321
North America dominates the global cell lysis market
The cell lysis market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2018, North America accounted for the largest share of the cell lysis market. The large share of North America can be attributed to factors such as the Growing stem cell and cancer research activities and the expanding biotechnology & pharmaceutical industries
Key Players of Market:
The major players in the cell lysis market are Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Danaher Corporation (US), Bio-Rad Laboratories (US), Cell Signaling Technology Inc. (US), Miltenyi Biotec (Germany), Roche Diagnostics (Switzerland), and QIAGEN N.V. (Netherlands).
Cell Lysis/Cell Fractionation
US EVERY YEAR FOR THEIR
HOME ❯ TOP MARKET REPORTS ❯ CELL LYSIS/CELL FRACTIONATION MARKET
Cell Lysis/Cell Fractionation Market by Product (Consumables
(Enzymes, Detergent), Instruments (Sonicators)), Cell Type
(Mammalian), Application (Protein Purification), End User
(Biopharmaceutical & Biotechnology Companies) - Global Forecast to
[172 Pages Report] The global cell lysis market size is projected to reach USD 4.1 billion by 2026
from USD 2.9 billion in 2021, at a CAGR of 7.2% during the forecast period. Growth of the market is
driven mainly by increasing government funding for research, high prevalence of diseases and
growing focus on personalized medicine.
To know about the assumptions considered for the study, download the pdf brochure
Covid -19 Impact On The Cell Lysis Market
Due to the rapid spread of the coronavirus, the demand for diagnostic kits and other critical care
medical devices has witnessed exponential growth in the last two quarters. Currently, healthcare
provider facilities across the globe are overwhelmed with patient submissions for COVID-19
screening & treatment. This has resulted in severe disruptions in clinical workflows within inpatient
care facilities, leading to prioritizing critical patient care procedures by provider facilities. However,
government and corporate investments have increased significantly to drive the manufacturing and
supply of medical supplies required to cater to infected patients. This has pressured stakeholders to
strengthen their existing manufacturing capabilities and supply chains. The life sciences industry
and multinational organizations & smaller companies are working round-the-clock to meet this
demand and make tests available.
Global Cell Lysis Market Dynamics
DRIVER: Increasing government funding for research
Researchers utilize disrupted cells to study an organelle’s morphology and functi